joelam33

Almost done taking a Deep Breath and will try to Breakout Again

NASDAQ:DVAX   Dynavax Technologies Corporation
On July 21 @ $11.31/share, I mentioned that DVAX is going to take a Deep Breath before trying to Breakout of the 16 Years Descending Triangle. By the time it closed on July 21, it created a Candlestick pattern of Evening Star (Bearish downtrend). Now it is about $8.61/share that is about 30% decline since then. Not too bad for people who shorted the stock.
The Stochastic is approaching oversold, It is on Fib 0.382, On Trendline Support. Look for chart reversal pattern and confirmation before adding more. Best of luck and watch out for the overall market that might drag the stock down :)

Evening Star created a very strong bearish trend, as a result. People ignored recent good news. This includes the following
1) Dynavax and Medigen Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
2) Committee to vote on addition of the following medications to THMP formulary (Vote Required) HEPLISAV B Vote on July 31 hhs.texas.gov/about-...ory-committee-agenda

------
List of Covid-19 Partnership
Sinovac Biotech
Clover clinicaltrials.gov/ct2/show/NCT04405908
Medicago clinicaltrials.gov/ct2/show/NCT04450004
Medigen clinicaltrials.gov/ct2/show/NCT04487210

Hep B
Times Pharmacy, have partnered with Hep Free Hawaii to provide HEPLISAV-B
Engerix-B vs HEPLISAV-B www.cdc.gov/mmwr/vol...s/67/wr/mm6715a5.htm

Universal influenza (flu) vaccine.
DVAX announced that it has entered into a collaboration agreement with Icahn School of Medicine at Mount Sinai (Mount Sinai) to develop a universal influenza (flu) vaccine.

HIV
NIAID - clinicaltrials.gov/ct2/show/NCT04177355
NIAID - HBV Vaccination in Persons Living With HIV clinicaltrials.gov/ct2/show/NCT04193189

I believe there are several more studies or partners. Please post it here if I missed any.


Happy Trading.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.